High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Amount
- $1,500,000
- Closes
- Mar 5, 2027 (in 187 days)
Similar opportunities open now
- High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Mar 2027
- Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Nov 2027
- Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Dec 2027
- Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Dec 2027
- Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Nov 2027
Classification and identifiers
- Solicitation number
- RFA-DA-25-060
- Assistance listing (CFDA)
- 93.279
Amount
$1,500,000
Who can apply
State government agencies can apply here. Check the eligibility details below to see if your organization fits.
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as de...
About this opportunity
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelin...